AKT1 and hepatocellular carcinoma: In this regard, formative studies noted mutations and dysregulated expression of the phosphatidylinositol 3-kinase (PI3K)/the serine-threonine protein kinase (Akt)/mammalian target of the rapamycin (mTOR) signaling pathway in HCC.